Peer Review reports
From: AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
| Original Submission | ||
|---|---|---|
| 3 Aug 2018 | Submitted | Original manuscript |
| 31 Oct 2018 | Reviewed | Reviewer Report - Anne-Marie Ruppert |
| 10 Jan 2019 | Reviewed | Reviewer Report - Reviewer 2 |
| 16 Feb 2019 | Author responded | Author comments - Mark-Oliver Zahn |
| Resubmission - Version 2 | ||
| 16 Feb 2019 | Submitted | Manuscript version 2 |
| 28 Feb 2019 | Reviewed | Reviewer Report - Reviewer 2 |
| 15 Mar 2019 | Reviewed | Reviewer Report - Anne-Marie Ruppert |
| 4 Apr 2019 | Author responded | Author comments - Mark-Oliver Zahn |
| Resubmission - Version 3 | ||
| 4 Apr 2019 | Submitted | Manuscript version 3 |
| 12 Apr 2019 | Author responded | Author comments - Mark-Oliver Zahn |
| Resubmission - Version 4 | ||
| 12 Apr 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 15 Apr 2019 | Editorially accepted | |
| 10 May 2019 | Article published | 10.1186/s12885-019-5618-0 |
You can find further information about peer review here.